<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gender differences in outcome following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> have frequently been observed and attributed to the actions of steroid hormones </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="28" ids="17026">Progesterone</z:chebi> has been shown to possess neuroprotective properties following <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e>, with respect to decreasing lesion volume and improving functional recovery </plain></SENT>
<SENT sid="2" pm="."><plain>The present study was designed to determine the mechanisms of <z:chebi fb="28" ids="17026">progesterone</z:chebi> neuroprotection, and whether these relate to the <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Male mice underwent either 60 min or permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and received <z:chebi fb="28" ids="17026">progesterone</z:chebi> (8 mg/kg ip) or vehicle 1 h, 6 h and 24 h post-MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>Forty-eight hours following transient MCAO, structural magnetic resonance imaging revealed a significant decrease in the amount of edematous tissue present in <z:chebi fb="28" ids="17026">progesterone</z:chebi>-treated mice as compared with vehicle </plain></SENT>
<SENT sid="5" pm="."><plain>Using real-time PCR we found that <z:chebi fb="28" ids="17026">progesterone</z:chebi> treatment significantly suppressed the injury-induced upregulation of interleukin (IL)-1beta, transforming growth factor (TGF)beta2, and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS)-2 mRNAs in the ipsilateral hemisphere while having no effect on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="28" ids="17026">Progesterone</z:chebi> treatment following permanent MCAO also resulted in a significant decrease in lesion volume </plain></SENT>
<SENT sid="7" pm="."><plain>This was not apparent in mice lacking a functional NOS-2 gene </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, <z:chebi fb="28" ids="17026">progesterone</z:chebi> is neuroprotective in both permanent and <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e>, and this effect is related to the suppression of specific aspects of the <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>